Recent Finacing
Recent Raise
BNJ BioPharma uses AI to design multi-target oncology therapeutics and targeted protein degraders, advancing a KRAS‑mutant pancreatic candidate through animal efficacy studies and a planned domestic Phase 1 trial.
Focus Areas
Recent Investors
Funding round
Investor